The Terrible, Horrible, No Good, Very Bad Pharma Day*
A challenge You are passionate about providing an intervention (drug or device) to a group…
Uncategorized
There are 99 articles in this category
None Better than One? (A Brief Note on VC in Smaller Hubs)
Biotech venture funding metrics continue at historic highs, highlighting that the robust financing environment…
Blood: Underappreciated Resource in the Health/Disease?
Alternative title: Pitching a VC on Disruption of Blood Testing You may have seen…
#MHVF Approaches to Drug Development
Today I had the chance for a panel conversation with Geeta Vemuri from Baxter Ventures…
Precision in Oncology: Using the Macro and Micro
Last week, the New York Times had a nice piece "A Faster Way to…
Case Study: When does “technology” turn into medical device
This semester I've embarked on an adventure to co-teach a class in the University…
What is the optimal biotech burn rate?
Ethan Perlstein, founder of Perlstein Lab, asked a question on Twitter and got some great…
We All Need a Risk Framework
I recently read “The Most Important Thing Illuminated: Uncommon Sense for the Thoughtful Investor”…
Supporting Biotech Development in Madison
As part of our follow up to our recent Biotech in Wisconsin Meetup about…
How Could Science #BreaktheInternet?
I saw the Breakthrough Prizes announced this weekend and was excited to learn about…
Load More